Psychiatry

The treatment was well-tolerated with a safety profile consistent with previous clinical trials.

Lamotrigine is currently being used as a maintenance therapy for bipolar disorder.

Viloxazine was approved in April by the FDA for pediatric ADHD patients between 6-17 years old.

The dual orexin receptor antagonist notably demonstrates a positive benefit-risk balance for patients

Suspected suicide attempts have increased more among females.

Baseline eGFR and increasing age were good predictors of eGFR.

Reported HRQOL remains consistent in youth with T1D, but multiple comorbidities and mental health conditions linked to decline.

REL-1017 was more effective when administered earlier rather than later.

The higher levels of visits were mostly maintained throughout the pandemic.

Externalizing ADHD symptoms was linked to suicidality.

The reduction in heavy drinking in individuals between 18-25 years old is likely due to government restrictions on social gatherings.

Greater symptoms of depression, anxiety, and ADHD were associated with less sleep.

The device is designed to assist in diagnosis to provide early intervention and appropriate care.

New research sheds light on the relationship between sleep timing and the risk of developing major depressive disorder (MDD).

The oral combination therapy can also be used as acute treatment for manic or mixed episodes.

Internet-delivered CBT may be an efficient and convenient means for addressing behaviors that exacerbate atopic dermatitis-related symptoms.

A survey at ACC 2021 showed 38% of cardiology professionals were burnt out during COVID-19. What factors in the field have already made it difficult to cope?

A cardiologist and wellness expert discusses new findings showing more than one-third of her peers were burnt out from experiences during the pandemic.

Prescription rates of buprenorphine and opioid analgesics for OUD fell during the COVID-19 pandemic for new patients, but existing treatment was not affected.

Dr. Todd Hutton gives tips for how to best handle the ongoing mental health crisis.

A recent JAMA study shows a decrease in suicide deaths between 2019-2020, despite a 17% overall increase in mortality.

Approximately 30% of schizophrenia patients do not respond to their first treatment.

Andrew J. Cutler, MD discusses new research into the efficacy and safety of a D-ATS treatment in children with ADHD.

Clozapine is considered the gold standard of schizophrenia treatment.